a 57-year-old-male patient with acute myelogenous leukemia in second relapse who was refractory to bhac . amp [ behenoyl arabinosyl cytosine ( bhac ) , aclacinomycin , 6-mercaptopurine and prednisolone ( psl ) ] and bhac . dvp [ bhac , daunomycin , vincristine and psl ] was treated with an intermediate-dose cytosine arabinoside ( id ara-c ) regimen .
C0023467
acute myelogenous leukemia
C0011015
daunomycin